Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07578363 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

An Investigation of FID 123472 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness in Adults

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Mar 2027 to Jan 2027
    • Eligibility criteria expanded, about 17 words
    • Secondary endpoints: 3 to 4
    v3
  2. Primary endpoint(s) modified
    • Eligibility criteria shortened, about 58 words
    • Secondary endpoints revised (3)
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Alcon Research
30 trials monitored
See 3 trials at risk
The purpose of this study is to evaluate the efficacy and safety of an investigational ophthalmic solution in adults with ocular redness caused by minor eye irritations.
Trial Details
NCT Number NCT07578363
Lead Sponsor Alcon Research
Conditions
(from sponsor)		 Ocular Hyperemia
Enrollment 178 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov